Endocrine-disrupting properties in vivo of widely used azole fungicides.
about
Concentration addition, independent action and generalized concentration addition models for mixture effect prediction of sex hormone synthesis in vitroA predictive data-driven framework for endocrine prioritization: a triazole fungicide case studyResistance to antifungals that target CYP51.Similar causes of various reproductive disorders in early lifeDrug strategies targeting CYP51 in neglected tropical diseasesAzole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.Molecular aspects of azoles-induced teratogenesis.Human and ecological risk assessment of a crop protection chemical: a case study with the azole fungicide epoxiconazole.Environmental toxins: alarming impacts of pesticides on male fertility.Inhibition of rat and human steroidogenesis by triazole antifungals.Malformation spectrum induced by ketoconazole after single administration to pregnant rats during the critical period - comparison with vitamin A-induced malformation spectrum.Evaluating the enantioselective distribution, degradation and excretion of epoxiconazole in mice following a single oral gavage.Organic neem compounds inhibit soft-rot fungal growth and improve the strength of anthracite bricks bound with collagen and lignin for use in iron foundry cupolas.Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro.Epoxiconazole-induced degeneration in rat placenta and the effects of estradiol supplementation.Acute toxicity and bioconcentration of fungicide tebuconazole in zebrafish (Danio rerio).Effects of estrogen coadministration on epoxiconazole toxicity in rats.A successful case of Cushing's disease pregnancy treated with ketoconazole.Prenatal epoxiconazole exposure effects on rat postnatal development.Potential Health Risk of Endocrine Disruptors in Construction Sector and Plastics Industry: A New Paradigm in Occupational Health.
P2860
Q28535588-906802F6-D71E-4DA3-AEA7-B3D423B390ABQ28828276-2C8ADA34-C632-4CC2-AB80-1C115503C226Q34276700-25DFA95B-B048-4478-9E23-D2325D95B2B4Q34394422-2484592D-F5B7-46E6-B0E9-827CAAB0F453Q34622554-612DBF23-02AD-4119-BBA5-93179F96EEC1Q36667070-113D1CC7-B709-4F35-B802-DFEA0C407CFFQ37681552-AF7B1006-DC87-48E5-B552-D1CF0AF08CF8Q38165985-8CB1DC92-2753-4110-BE46-25AF1BCDE95DQ38172050-F3F158E3-67A7-4998-AE0D-D4A2EDE24745Q39770676-F9084605-DF2C-4743-8DF8-DE0A63259B67Q39971000-00D7010F-D5B9-4E0D-9340-497F0D59D2E4Q40800373-B28006E0-5EFC-42A3-BD67-83205C39AB94Q41096979-BAFA42BE-4AD3-42FA-A768-DBB3D62CC043Q41681447-510C2EF0-DCEE-46C1-B339-18797C047239Q43637092-EF96DDEB-7376-4B4F-9739-802C3EED91C7Q45694184-A17AD66C-72E4-4EF3-BD70-59712547B13EQ46319912-52173BAE-0673-419C-818B-BEB1897CDE8FQ51065286-3007E399-140C-48F6-97D5-996F430F134EQ51846602-CDA8587F-B7A5-4F2F-8FA1-B73DEFE56B4EQ55669741-CF1411F8-6549-4C32-B2C3-C19B38B26FB3
P2860
Endocrine-disrupting properties in vivo of widely used azole fungicides.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@en
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@nl
type
label
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@en
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@nl
prefLabel
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@en
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@nl
P2093
P2860
P50
P1476
Endocrine-disrupting properties in vivo of widely used azole fungicides.
@en
P2093
Axelstad M
Metzdorff S
Nellemann C
P2860
P304
P356
10.1111/J.1365-2605.2007.00838.X
P577
2007-12-06T00:00:00Z